SOPHiA GENETICS SA (SOPH)
4.60
-0.27
(-5.54%)
USD |
NASDAQ |
Dec 09, 16:00
4.615
+0.02
(+0.33%)
After-Hours: 20:00
SOPHiA GENETICS EPS Diluted (Quarterly): -0.2954 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| BeOne Medicines Ltd. | 1.092 |
| AC Immune SA | -0.1964 |
| CRISPR Therapeutics AG | -1.166 |
| Addex Therapeutics Ltd. | -2.099 |
| NewCelX Ltd. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -20.02M |
| Revenue (Quarterly) | 19.46M |
| Total Expenses (Quarterly) | 39.48M |
| Enterprise Value | 293.86M |
| Gross Profit Margin (Quarterly) | 66.32% |
| Profit Margin (Quarterly) | -102.9% |
| Earnings Yield | -24.26% |
| Normalized Earnings Yield | -23.91 |